MTOR and neoplasm with perivascular epithelioid cell differentiation: Retrospective analyses of patients with advanced PEComa treated with mTOR inhibitors sirolimus, temsirolimus, or everolimus showed evidence of antitumor activity,4-8 suggesting that mTOR inhibitors may improve outcomes compared with chemotherapy and tyrosine kinase inhibitors.